中华麻醉学杂志
中華痳醉學雜誌
중화마취학잡지
CHINESE JOURNAL OF ANESTHESIOLOGY
2011年
1期
28-30
,共3页
冀翔宇%王世端%刘英志%周赞宫%朱德璋
冀翔宇%王世耑%劉英誌%週讚宮%硃德璋
기상우%왕세단%류영지%주찬궁%주덕장
右美托咪啶%剂量效应关系,药物%异氟醚
右美託咪啶%劑量效應關繫,藥物%異氟醚
우미탁미정%제량효응관계,약물%이불미
Dexmedetomidine%Dose-response relationship,drug%Isoflurane
目的 探讨右美托咪啶对异氟醚抑制切皮时患者体动反应的肺泡气最低有效浓度(MAC)的影响.方法 择期全身麻醉下行上腹部手术患者,年龄40~60岁,ASA分级Ⅰ或Ⅱ级,体重指数22~27 kg/m2,采用随机数字表法,将患者随机分为3组:对照组(C组)、小剂量右美托咪啶组(D1组)和大剂量右美托咪啶组(D2组).麻醉诱导前静脉输注右美托咪啶(生理盐水稀释至15 ml)0.4 μg/kg(D1组)、0.8μg/kg(D2组)及生理盐水15 ml(C组),15 min内输注完毕.静脉注射芬太尼-异丙酚-琥珀酰胆碱麻醉诱导,气管插管后机械通气并开启异氟醚挥发罐.采用序贯法确定麻醉维持期间异氟醚的呼气末浓度,C组、D1组和D2组第1例患者异氟醚呼气末浓度分别设定为1.0%、0.8%和0.6%,当异氟醚呼气末浓度达到预设水平并维持15 min以上,且肌颤搐恢复到对照值90%以上时开始手术,相邻浓度差值为0.2%.于切皮时评估患者体动反应,以各交叉点异氟醚呼气末浓度的均数为MAC,并计算95%可信区间(CI).结果 C组、D1组和D2组入选病例分别为15、17和16例.异氟醚抑制切皮时体动反应的MAC及其95%CI分别为:C组(1.03±0.23)%(95%CI 0.83%~1.21%)、D1组(0.72±0.19)%(95%CI 0.58%~0.85%)、D2组(0.51±0.27)%(95%CI 0.30%~0.71%).与C组比较,D1组和D2组MAC降低(P<0.01),D2组MAC明显低于D1组(P<0.05).结论 右美托咪啶可明显降低异氟醚抑制切皮时患者体动反应的MAC,且与剂量有关.
目的 探討右美託咪啶對異氟醚抑製切皮時患者體動反應的肺泡氣最低有效濃度(MAC)的影響.方法 擇期全身痳醉下行上腹部手術患者,年齡40~60歲,ASA分級Ⅰ或Ⅱ級,體重指數22~27 kg/m2,採用隨機數字錶法,將患者隨機分為3組:對照組(C組)、小劑量右美託咪啶組(D1組)和大劑量右美託咪啶組(D2組).痳醉誘導前靜脈輸註右美託咪啶(生理鹽水稀釋至15 ml)0.4 μg/kg(D1組)、0.8μg/kg(D2組)及生理鹽水15 ml(C組),15 min內輸註完畢.靜脈註射芬太尼-異丙酚-琥珀酰膽堿痳醉誘導,氣管插管後機械通氣併開啟異氟醚揮髮罐.採用序貫法確定痳醉維持期間異氟醚的呼氣末濃度,C組、D1組和D2組第1例患者異氟醚呼氣末濃度分彆設定為1.0%、0.8%和0.6%,噹異氟醚呼氣末濃度達到預設水平併維持15 min以上,且肌顫搐恢複到對照值90%以上時開始手術,相鄰濃度差值為0.2%.于切皮時評估患者體動反應,以各交扠點異氟醚呼氣末濃度的均數為MAC,併計算95%可信區間(CI).結果 C組、D1組和D2組入選病例分彆為15、17和16例.異氟醚抑製切皮時體動反應的MAC及其95%CI分彆為:C組(1.03±0.23)%(95%CI 0.83%~1.21%)、D1組(0.72±0.19)%(95%CI 0.58%~0.85%)、D2組(0.51±0.27)%(95%CI 0.30%~0.71%).與C組比較,D1組和D2組MAC降低(P<0.01),D2組MAC明顯低于D1組(P<0.05).結論 右美託咪啶可明顯降低異氟醚抑製切皮時患者體動反應的MAC,且與劑量有關.
목적 탐토우미탁미정대이불미억제절피시환자체동반응적폐포기최저유효농도(MAC)적영향.방법 택기전신마취하행상복부수술환자,년령40~60세,ASA분급Ⅰ혹Ⅱ급,체중지수22~27 kg/m2,채용수궤수자표법,장환자수궤분위3조:대조조(C조)、소제량우미탁미정조(D1조)화대제량우미탁미정조(D2조).마취유도전정맥수주우미탁미정(생리염수희석지15 ml)0.4 μg/kg(D1조)、0.8μg/kg(D2조)급생리염수15 ml(C조),15 min내수주완필.정맥주사분태니-이병분-호박선담감마취유도,기관삽관후궤계통기병개계이불미휘발관.채용서관법학정마취유지기간이불미적호기말농도,C조、D1조화D2조제1례환자이불미호기말농도분별설정위1.0%、0.8%화0.6%,당이불미호기말농도체도예설수평병유지15 min이상,차기전휵회복도대조치90%이상시개시수술,상린농도차치위0.2%.우절피시평고환자체동반응,이각교차점이불미호기말농도적균수위MAC,병계산95%가신구간(CI).결과 C조、D1조화D2조입선병례분별위15、17화16례.이불미억제절피시체동반응적MAC급기95%CI분별위:C조(1.03±0.23)%(95%CI 0.83%~1.21%)、D1조(0.72±0.19)%(95%CI 0.58%~0.85%)、D2조(0.51±0.27)%(95%CI 0.30%~0.71%).여C조비교,D1조화D2조MAC강저(P<0.01),D2조MAC명현저우D1조(P<0.05).결론 우미탁미정가명현강저이불미억제절피시환자체동반응적MAC,차여제량유관.
Objective To investigate the effect of dexmedetomidine on minimum alveolar concentration (MAC) of isoflurane required to inhibit the body movement during skin incision. Methods Forty-eight ASA Ⅰ or Ⅱ patients aged 40-60 yr with body mass index of 22-27 kg/m2 undergoing elective upper abdominal surgery under general anesthesia were randomly divided into 3 groups: control group (group C, n = 15);low dose dexmedetomidine group (group D1, n = 17) and high dose dexmedetomidine group (group D2, n = 16). The patients were unpremedicated. Dexmedetomidine 0.4 and 0.8 μg/kg in normal saline (NS) 15 ml was infused over 15 min before induction of anesthesia in D1 and D2 groups respectively. Anesthesia was induced with fentanyl-propofol-succinylcholine. The patients were mechanically ventilated after tracheal intubation. Anesthesia was maintained with isoflurane. MAC of isoflurane was determined by up-and-down technique. The initial end-tidal isofiurane concentration was set at 1.0%, 0.8% and 0.6% in C, D1 and D2 groups respectively. Each time the end-tidal isoflurane concentration was increased/decreased by 0.2%. Skin incision was made after 15 min of equilibration, when the twitch height returned to more than 90% of its control value. Movement of body and limbs including swallowing and coughing were carefully looked for when skin incision was made. MAC of isoflurane was the mean of end-tidal concentration of isoflurane of each crossover pair, and 95 % CI was calculated. Results MAC of isoflurane was significantly decreased in D1 and D2 groups as compared with group C and in group D2 as compared with group D1( P < 0.05 or 0.01 ). Conclusion Dexmedetomidine can significantly decrease MAC of isoflurane required to inhibit the body movement during skin incision in a dose-dependent manner.